GPAS 2025: Shaping the Future of Bleeding Disorder Care
The World Federation of Hemophilia (WFH) recently shared an insightful post on X:
”At GPAS 2025, global experts explored the evolving treatment landscape for bleeding disorders—highlighting innovations in hemophilia and VWD care, and addressing challenges in access and reimbursement. A timely look at what’s ahead in care.”
At GPAS 2025, leading global experts Jamie O’Hara, Alok Srivastava, Nathan Connell and Cedric Hermans convened to discuss the rapidly evolving treatment landscape for bleeding disorders.
Sessions spotlighted innovation in hemophilia and von Willebrand disease (VWD) care, including novel therapeutics, personalized medicine, and gene-based approaches.
Critical dialogue also addressed ongoing challenges in access, affordability, and reimbursement.
The meeting offered a timely and forward-looking perspective on the future of equitable care delivery!
Find more footage from the webinar in the gallery.
Hemostasis Today, your daily update on the World of Hemophilia.
-
Apr 12, 2026, 11:36Ifeanyichukwu Ifechidere: From Running Tests to Trusting Interpretation in Coagulation
-
Apr 12, 2026, 11:30Zack Rosanova: What Happens to Your Brain Without Sleep
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine